These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2156387)

  • 1. Evaluation of a reassortant rhesus rotavirus vaccine in young children.
    Tajima T; Thompson J; Wright PF; Kondo Y; Tollefson SJ; King J; Kapikian AZ
    Vaccine; 1990 Feb; 8(1):70-4. PubMed ID: 2156387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children.
    Wright PF; King J; Araki K; Kondo Y; Thompson J; Tollefson SJ; Kobayashi M; Kapikian AZ
    J Infect Dis; 1991 Aug; 164(2):271-6. PubMed ID: 1649874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine.
    Simasathien S; Migasena S; Samakoses R; Pitisuttitham P; Sangaroon P; Aree C; Bishop R; Bugg H; Davidson BL; Vesikari T
    Pediatr Infect Dis J; 1994 Jul; 13(7):590-6. PubMed ID: 7970945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity.
    Vesikari T; Varis T; Green K; Flores J; Kapikian AZ
    Vaccine; 1991 May; 9(5):334-9. PubMed ID: 1651610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
    Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
    Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.
    Flores J; Perez-Schael I; Blanco M; Vilar M; Garcia D; Perez M; Daoud N; Midthun K; Kapikian AZ
    J Clin Microbiol; 1989 Mar; 27(3):512-8. PubMed ID: 2541168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants.
    Clements-Mann ML; Dudas R; Hoshino Y; Nehring P; Sperber E; Wagner M; Stephens I; Karron R; Deforest A; Kapikian AZ
    Vaccine; 2001 Sep; 19(32):4676-84. PubMed ID: 11535316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human-rhesus reassortant rotavirus vaccines: safety and immunogenicity in adults, infants, and children.
    Halsey NA; Anderson EL; Sears SD; Steinhoff M; Wilson M; Belshe RB; Midthun K; Kapikian AZ; Chanock RM; Samorodin R
    J Infect Dis; 1988 Dec; 158(6):1261-7. PubMed ID: 2848902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential administration of two human-rhesus rotavirus reassortant strains of VP7 serotype 1 and 2 specificity to infants and young children.
    Kobayashi M; Araki K; Thompson J; Tollefson SJ; Wright PF
    J Infect Dis; 1993 Mar; 167(3):748-52. PubMed ID: 8382725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and reactogenicity of lowered doses of rhesus rotavirus vaccine strain MMU 18006 in young children.
    Rennels MB; Losonsky GA; Shindledecker CL; Hughes TP; Kapikian AZ; Levine MM
    Pediatr Infect Dis J; 1987 Mar; 6(3):260-4. PubMed ID: 3033593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate rotavirus vaccine (rhesus rotavirus strain) in children: an evaluation.
    Wright PF; Tajima T; Thompson J; Kokubun K; Kapikian A; Karzon DT
    Pediatrics; 1987 Oct; 80(4):473-80. PubMed ID: 2821477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of human rotavirus vaccine strain M37 in adults, children, and infants.
    Midthun K; Halsey NA; Jett-Goheen M; Clements ML; Steinhoff M; King JC; Karron R; Wilson M; Burns B; Perkis V
    J Infect Dis; 1991 Oct; 164(4):792-6. PubMed ID: 1654365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development.
    Green KY; Taniguchi K; Mackow ER; Kapikian AZ
    J Infect Dis; 1990 Apr; 161(4):667-79. PubMed ID: 2156942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
    Kapikian AZ; Flores J; Hoshino Y; Midthun K; Gorziglia M; Green KY; Chanock RM; Potash L; Sears SD; Clements ML
    Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants.
    Perez-Schael I; Blanco M; Vilar M; Garcia D; White L; Gonzalez R; Kapikian AZ; Flores J
    J Clin Microbiol; 1990 Mar; 28(3):553-8. PubMed ID: 2157737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group.
    Rennels MB; Losonsky GA; Young AE; Shindledecker CL; Kapikian AZ; Levine MM
    Am J Dis Child; 1990 May; 144(5):601-4. PubMed ID: 2330930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative evaluation of the safety and immunogenicity of a single dose of unbuffered oral rhesus rotavirus serotype 3, rhesus/human reassortant serotypes 1, 2 and 4 and combined (tetravalent) vaccines in healthy infants.
    Pichichero ME; Marsocci SM; Francis AB; Green JL; Disney FA; Rennels MB; Lewis ED; Sugarman L; Losonsky GA; Zito E
    Vaccine; 1993; 11(7):747-53. PubMed ID: 8393606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups.
    Madore HP; Christy C; Pichichero M; Long C; Pincus P; Vosefsky D; Kapikian AZ; Dolin R
    J Infect Dis; 1992 Aug; 166(2):235-43. PubMed ID: 1321858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006.
    Losonsky GA; Rennels MB; Lim Y; Krall G; Kapikian AZ; Levine MM
    Pediatr Infect Dis J; 1988 Jun; 7(6):388-93. PubMed ID: 2839813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactogenicity and antigenicity of rhesus rotavirus vaccine (MMU-18006) in newborn infants in Venezuela.
    Flores J; Daoud G; Daoud N; Puig M; Martinez M; Perez-Schael I; Shaw R; Greenberg HB; Midthun K; Kapikian AZ
    Pediatr Infect Dis J; 1988 Nov; 7(11):776-80. PubMed ID: 2852792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.